Low Efficacy of Transdermal Sumatriptan in Migraine

ISSN： 1172-7047

Source： CNS Drugs, Vol.25, Iss.2, 2011-02, pp. : 171-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine

By Tfelt-Hansen Peer Hougaard Anders

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 1, 2013-01 ,pp. : 91-103

Informa Healthcare

Access to resources Recommend Favorite

Intranasal Sumatriptan: In Adolescents with Migraine

By Curran Monique P. Evans Hannah C. Wagstaff Antona J.

CNS Drugs, Vol. 19, Iss. 4, 2005-01 ,pp. : 335-343

Adis International

Access to resources Recommend Favorite

Efficacy, end points and eventualities: sumatriptan/naproxen versus butalbital/paracetamol/caffeine in the treatment of migraine

By Fox Anthony W

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 5, 2012-09 ,pp. : 513-516

Informa Healthcare

Access to resources Recommend Favorite

Oral Sumatriptan Pharmacokinetics in the Migraine State

By Sramek J.J.

Clinical Drug Investigation, Vol. 17, Iss. 2, 1999-02 ,pp. : 137-144

Adis International

Access to resources Recommend Favorite

Metoclopramide, sumatriptan for migraine treatment in the ED

Inpharma, Vol. 1, Iss. 1482, 2005-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite